FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

16683002: Progesterone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
28249012 Progesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
28249012 Progesterone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
28249012 Progesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
477894010 PRG - Progesterone en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
55641000195113 progesterone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70691000195113 Progesteron de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
835871000172110 progestérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
835871000172110 progestérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
55641000195113 progesterone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70691000195113 Progesteron de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Progesterone Is a Ovarian hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Progestational hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Progesterone derivative false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Pregnane (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Steroid hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Has disposition Progestational hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Has disposition Ovarian hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Has disposition Progesterone receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Substance with progesterone receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Medroxyprogesterone acetate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 500mg/2.5mL injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 200mg tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely medroxyprogesterone acetate 400 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Megestrol acetate 40 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Megestrol acetate 160 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Gestronol (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing medroxyprogesterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Parenteral medroxyprogesterone (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing estradiol and norethisterone acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing ethinylestradiol and norgestrel (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Médicament progestatif The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing medroxyprogesterone acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing ethisterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Megestrol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyprogestérone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
17 Hydroxyprogesterone measurement, serum Component False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing dydrogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning caused by combined estrogen AND progestogen Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing hydroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethisterone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing norethisterone acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing noretynodrel (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norgestrel-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing megestrol acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Flurogestone acetate preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing norgestomet (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing altrenogest (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Melengestrol preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Melengestrol acetate preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Delmadinone acetate preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 104mg injection suspension 0.65mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norelgestromin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ovarian hormone poisoning NOS Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyprogesterone hexanoate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogest ac [endocrine] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethisterone [endocrine] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethynodiol diacetate [progestogen oral contraceptive] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogest acetate [progestogen oral contraceptive] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norgestrel [progestogen oral contraceptive] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethisterone [progestogen oral contraceptive] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethisterone enanthate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Gestronol hexanoate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogest ac [malignancy] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethisterone [malignancy] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethisterone ac [malignancy] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogen- and medroxyprogesterone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing ethinylestradiol and norgestimate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate + estradiol cyprionate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing ethinylestradiol and norethisterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing desogestrel and ethinylestradiol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing ethinyl estradiol and ethynodiol diacetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethindrone + ethinyl oestradiol + ferrous fumarte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing mestranol and norethisterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Levonorgestrel + estradiol transdermal system The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 150mg/1mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol 600micrograms / norelgestromin 6mg transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol- and norelgestromin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Saliva 17alpha-hydroxyprogesterone measurement (procedure) Component False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 3
Norethisterone acetate 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethindrone 0.35mg tablet (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Megestrol acetate 40 mg/mL oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Desogestrel + ethinyl estradiol + ethinyl oestradiol 0.15mg/0.01mg/0.01mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Desogestrel + ethinyl oestradiol 0.15mg/0.03mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol + estradiol + norgestimate 1mg/1mg/0.09mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Oestradiol + norethindrone acetate 1mg/0.5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol cypionate + medroxyprogesterone acetate 5mg/25mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 35 microgram and etynodiol diacetate 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl oestradiol + ethynodiol diacetate 50mcg/1mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + etonogestrel 2.7mg/11.7mg vaginal ring The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + ferrous fumarate + norgestrel 0.03mg/75mg/0.3mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only ethinyl estradiol 0.035 mg and norethisterone 0.5 mg/1 each oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl oestradiol + norethindrone acetate 20mcg/1mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + norethindrone acetate 30mcg/1.5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + norgestimate 0.035mg/0.25mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + norgestrel 0.05mg/0.5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norelgestromin+ethinyl estradiol 6mg/0.75mg patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Megestrol acetate 20 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing drospirenone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing drospirenone and ethinylestradiol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)

Start Page 2 of 3 End

This concept is not in any reference sets

Back to Start